Log | Progress In Mind

Log Type	Authored on	Log Message	Log Node	Authored by
Newsletter sent	Tue, 11/08/2022 - 12:04	Newsletter sent to:light26@hanmail.net		Анонимен
Newsletter sent	Tue, 11/08/2022 - 12:04	Newsletter sent to:thanato96@naver.com		Анонимен
Newsletter sent	Tue, 11/08/2022 - 12:04	Newsletter sent to:jade34901@gmail.com		Анонимен
Newsletter sent	Tue, 11/08/2022 - 12:04	Newsletter sent to:mindconsult@gmail.com		Анонимен
Newsletter sent	Tue, 11/08/2022 - 12:04	Newsletter sent to:seon0220@hanmail.net		Анонимен
Newsletter sent	Tue, 11/08/2022 - 12:04	Newsletter sent to:drhuesi@gmail.com		Анонимен
Newsletter sent	Tue, 11/08/2022 - 12:04	Newsletter sent to:psyrim@gmail.com		Анонимен
Newsletter sent	Tue, 11/08/2022 - 12:04	Newsletter sent to:salesk@progress.im		Анонимен
Newsletter sent	Tue, 11/08/2022 - 12:04	Newsletter sent to:tyoun@dumc.or.kr		Анонимен
Newsletter sent	Tue, 11/08/2022 - 12:04	Newsletter sent to:tilde0207@gmail.com		Анонимен
Newsletter sent	Tue, 11/08/2022 - 12:04	Newsletter sent to:jo-song94@hanmail.net		Анонимен
Newsletter sent	Tue, 11/08/2022 - 12:04	Newsletter sent to:lalumiere72@gmail.com		Анонимен
Newsletter sent	Tue, 11/08/2022 - 12:04	Newsletter sent to:gsooklee@gmail.com		Анонимен
Newsletter sent	Tue, 11/08/2022 - 12:04	Newsletter sent to:korea@progress.im		Анонимен
Newsletter sent	Tue, 11/08/2022 - 12:04	Newsletter sent to:kangzam@hanmail.net		Анонимен
Newsletter sending	Wed, 10/12/2022 - 13:23	Sending to 474		Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Анонимен
Newsletter opened	Fri, 07/31/2020 - 07:58	Opened		Анонимен
Newsletter sent	Tue, 11/08/2022 - 12:04	Newsletter Test sent to:jinc@lundbeck.com,lily@lundbeck.com		Анонимен
Newsletter opened	Fri, 07/31/2020 - 07:15	Opened		Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Анонимен
User created	Wed, 10/12/2022 - 13:23	User created		Анонимен
Newsletter opened	Fri, 07/31/2020 - 06:11	Opened		Анонимен
Newsletter clicked	Fri, 07/31/2020 - 05:53	Clicked https://japan.progress.im/ja/content/%E6%97%A5%E6%9C%AC%E3%81%AB%E3%81%8A%E3%81%91%E3%82%8B%E7%B2%BE%E7%A5%9E%E7%96%BE%E6%82%A3%E3%81%AB%E5%AF%BE%E3%81%99%E3%82%8B%E3%82%B9%E3%83%86%E3%82%A3%E3%82%B0%E3%83%9E%E3%81%8A%E3%82%88%E3%81%B3%E3%81%9D%E3%81		Анонимен
User created	Wed, 10/12/2022 - 13:23	User created		Анонимен

Log Type	Authored on	Log Message	Log Node	Authored by
Newsletter sent	Tue, 11/08/2022 - 12:04	Newsletter sent to:light26@hanmail.net		Анонимен
Newsletter sent	Tue, 11/08/2022 - 12:04	Newsletter sent to:thanato96@naver.com		Анонимен
Newsletter sent	Tue, 11/08/2022 - 12:04	Newsletter sent to:jade34901@gmail.com		Анонимен
Newsletter sent	Tue, 11/08/2022 - 12:04	Newsletter sent to:mindconsult@gmail.com		Анонимен
Newsletter sent	Tue, 11/08/2022 - 12:04	Newsletter sent to:seon0220@hanmail.net		Анонимен
Newsletter sent	Tue, 11/08/2022 - 12:04	Newsletter sent to:drhuesi@gmail.com		Анонимен
Newsletter sent	Tue, 11/08/2022 - 12:04	Newsletter sent to:psyrim@gmail.com		Анонимен
Newsletter sent	Tue, 11/08/2022 - 12:04	Newsletter sent to:salesk@progress.im		Анонимен
Newsletter sent	Tue, 11/08/2022 - 12:04	Newsletter sent to:tyoun@dumc.or.kr		Анонимен
Newsletter sent	Tue, 11/08/2022 - 12:04	Newsletter sent to:tilde0207@gmail.com		Анонимен
Newsletter sent	Tue, 11/08/2022 - 12:04	Newsletter sent to:jo-song94@hanmail.net		Анонимен
Newsletter sent	Tue, 11/08/2022 - 12:04	Newsletter sent to:lalumiere72@gmail.com		Анонимен
Newsletter sent	Tue, 11/08/2022 - 12:04	Newsletter sent to:gsooklee@gmail.com		Анонимен
Newsletter sent	Tue, 11/08/2022 - 12:04	Newsletter sent to:korea@progress.im		Анонимен
Newsletter sent	Tue, 11/08/2022 - 12:04	Newsletter sent to:kangzam@hanmail.net		Анонимен
Newsletter sending	Wed, 10/12/2022 - 13:23	Sending to 474		Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Анонимен
Newsletter opened	Fri, 07/31/2020 - 07:58	Opened		Анонимен
Newsletter sent	Tue, 11/08/2022 - 12:04	Newsletter Test sent to:jinc@lundbeck.com,lily@lundbeck.com		Анонимен
Newsletter opened	Fri, 07/31/2020 - 07:15	Opened		Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Анонимен
User created	Wed, 10/12/2022 - 13:23	User created		Анонимен
Newsletter opened	Fri, 07/31/2020 - 06:11	Opened		Анонимен
Newsletter clicked	Fri, 07/31/2020 - 05:53	Clicked https://japan.progress.im/ja/content/%E6%97%A5%E6%9C%AC%E3%81%AB%E3%81%8A%E3%81%91%E3%82%8B%E7%B2%BE%E7%A5%9E%E7%96%BE%E6%82%A3%E3%81%AB%E5%AF%BE%E3%81%99%E3%82%8B%E3%82%B9%E3%83%86%E3%82%A3%E3%82%B0%E3%83%9E%E3%81%8A%E3%82%88%E3%81%B3%E3%81%9D%E3%81		Анонимен
User created	Wed, 10/12/2022 - 13:23	User created		Анонимен

Patrocinado por

Progress in Mind Brazil

INSCRIÇÃO NEWSLETTER